Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesWorried about high-dose prescribing? Manage risk for you and your patient
APCToday, 04/17/09
Kaye NS et al. - This article describes how to manage potential risk to yourself and your patient by communicating effectively and documenting informed consent.
Related Articles
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: A randomised phase 2 trial
The Lancet, 11/05/09
Relevance Score: 48%
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Relevance Score: 46%
A RCT evaluating the effectiveness and cost-effectiveness of academic detailing versus postal prescribing feedback in changing GP antibiotic prescribing
Journal of Evaluation in Clinical Practice, 10/07/09
Relevance Score: 46%
Effect of a weight-based prescribing method within an electronic health record on prescribing errors
American Journal of Health-System Pharmacy, 11/10/09
Relevance Score: 45%
Back pain amongst 8,910 young Australian women: A longitudinal analysis of the use of conventional providers, complementary and alternative medicine (CAM) practitioners and self-prescribed CAM
Clinical Rheumatology, 10/21/09
Relevance Score: 45%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial
BMC Infectious Diseases, 12/03/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/03/09
Ustekinumab (Stelara): First-in-class human monoclonal antibody approved for treatment of moderate-to-severe plaque psoriasis
Formulary , 12/02/09
Today in Patient Counseling...keeping you current
Receive free subspecialty "5-minute updates" via email
Vascular Access-Related Bloodstream Infections in First Nations, Community and Teaching Canadian Dialysis Units, and Other Centre-Level Predictors
Nephron: Clinical Practice, 12/03/09
Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09
Male involvement in antenatal HIV counseling and testing: exploring mens perceptions in rural Malawi
AIDS Care, 11/23/09
Sponsor
Article Search
Sponsor